Renaissance Technologies - TRANSCEPT PHARMACEUTICALS IN ownership

TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 39 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q1 2014. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$594,000
+31.1%
293,539
+28.8%
0.00%
+100.0%
Q2 2014$453,000
+65.3%
227,846
+156.0%
0.00%0.0%
Q1 2014$274,000
+8.7%
89,000
+18.5%
0.00%0.0%
Q4 2013$252,000
-26.7%
75,100
-30.6%
0.00%0.0%
Q3 2013$344,000
+38.7%
108,200
+31.8%
0.00%0.0%
Q2 2013$248,00082,1010.00%
Other shareholders
TRANSCEPT PHARMACEUTICALS IN shareholders Q1 2014
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,031,874$6,258,0006.29%
NEA Management Company, LLC 2,086,755$6,427,0000.32%
BVF INC/IL 150,000$462,0000.07%
Central Square Management LLC 19,000$59,0000.06%
ABNER HERRMAN & BROCK LLC 20,000$62,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 137,000$422,0000.01%
SHEPHERD KAPLAN KROCHUK, LLC 31,000$95,0000.01%
Spark Investment Management LLC 11,100$34,0000.01%
Waverly Advisors, LLC 2,670$8,0000.00%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 33,384$103,0000.00%
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders